Back to Search
Start Over
Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy
- Source :
- Canadian Journal of Gastroenterology, Vol 23, Iss 3, Pp 180-184 (2009)
- Publication Year :
- 2009
- Publisher :
- Hindawi Limited, 2009.
-
Abstract
- BACKGROUND: Pegylated interferon (pegIFN) and ribavirin combination therapy remains the first-line treatment for chronic hepatitis C virus (HCV) infection. In contrast to the wealth of studies in treatment-naive patients, the effectiveness of retreatment in patients who have previously failed pegIFN-based therapy is largely unreported.
- Subjects :
- Diseases of the digestive system. Gastroenterology
RC799-869
Subjects
Details
- Language :
- English
- ISSN :
- 08357900
- Volume :
- 23
- Issue :
- 3
- Database :
- Directory of Open Access Journals
- Journal :
- Canadian Journal of Gastroenterology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.2555567b69fc42b6807edfc1730ef787
- Document Type :
- article
- Full Text :
- https://doi.org/10.1155/2009/470532